NDT Plus Advance Access originally published online on September 22, 2009
NDT Plus 2009 2(6):466-468; doi:10.1093/ndtplus/sfp113
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Acute renal failure, systemic lupus erythematosus and thrombotic microangiopathy following treatment with beta-interferon for multiple sclerosis: case report and review of the literature
1 Renal Unit
2 Department of Pathology, Salford Royal NHS Foundation Trust, Salford, Greater Manchester
3 Department of Internal Medicine, Trafford Healthcare NHS Trust, UK
Correspondence: Correspondence and offprint requests to: Thomas Hansen; E-mail: thomas.hansen{at}student.manchester.ac.uk
| Abstract |
|---|
We report a man with type 1 diabetes mellitus, autoimmune hypothyroidism and a tentative diagnosis of multiple sclerosis. Following treatment with beta interferon, he developed systemic lupus erythematosus with pericarditis, pleural effusions, cerebral infarction associated with anti-phospholipid antibody and acute renal failure due to thrombotic microangiopathy. He responded well to immunosuppression and anticoagulation. These complications may represent the most severe autoimmune reaction to beta interferon reported to date.
Key Words: acute renal failure anti-phospholipid syndrome beta-interferon multiple sclerosis systemic lupus erythematosus
Received for publication July 22, 2009. Accepted for publication July 27, 2009.